Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Cytopenia 1

Interventions

siltuximab 1decitabine and cedazuridine drug combination 1daratumumab 1apixaban 1Transplantation 1Simvastatin 1Observation 1Cord Blood Stem Cell Transplantation 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × decitabine and cedazuridine drug combination × Classical hematology × Clear all
NCT06802146 2026-04-23

Early Intervention in High Risk CCUS

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
108 enrolled
Classical hematology

Cytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡